HUL closes Oziva buyout at ₹1,680 cr valuation, paying ₹824 cr for residual 49%
Hindustan Unilever has fully absorbed plant-based nutrition D2C Oziva, paying ₹824 crore for the remaining 49% in Feb 2026 after its ₹264 crore majority deal in Dec 2022. The Aarti Gill–founded brand, with 70-80 SKUs and 95% revenue from nutrition, stayed loss-making in FY25 despite scaling from ₹80 crore in FY21.
What happened
OZiva · HUL completed full acquisition of plant-based nutrition D2C brand Oziva in Feb 2026, paying ₹824 crore for the remaining 49% stake at a ₹1,680 crore
Key facts
- ₹264 crore for 51% (Dec 2022)
- ₹824 crore for 49% (Feb 2026)
- valuation ₹1,680 crore
- FY21 revenue ₹80 crore
- 95% sales from nutrition
- 70-80 SKUs
Why this matters
The two-step structure—₹264 cr for majority in 2022, ₹824 cr for the residual 49% three years later—shows how staged buyouts let acquirers de-risk integration while founders capture upside, a template worth replicating for D2C tuck-ins.